Online Course

2019 CARE MOC Session 1: Scleroderma

Date:

Expires Oct 29, 2020

Program Information

CME: 4     MOC: 4

Assess your rheumatology medical knowledge and enhance your patient care. With 2019 CARE MOC Session 1 - Scleroderma you receive:

  • 12 case-based, multiple-choice questions with in-depth answer rationales
  • Up to 4 AMA PRA Category 1 Credit(s)™ and 4 ABIM MOC points with a passing score of 70% or higher

Target Audience
Rheumatologists, physicians, healthcare providers who care for patients with rheumatic diseases, and those interested or engaged in rheumatology research.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Identify factors for the uncommon but devastating event of scleroderma renal crisis (SRC)
  • Identify  appropriate candidates for of immunoablation by chemotherapy followed by stem cell rescue in SSc treatment and understand the potential complications of this therapeutic approach
  • Understand the different methods for ANA testing and their implications
  • Recognize the distinction between PH and PAH in this population and monitor for/ diagnose PAH
  • Monitor for/ identify SSc-related interstitial lung disease and implement treatment strategies

Registration Fees

Free for 2019 ACR/ARP Annual Meeting attendees.*

*This online activity is intended for 2019 ACR/ARP Annual Meeting attendees only.

CME and MOC Information

Accreditation Statement
The American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement
The ACR designates this online activity for a maximum of 4.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activities.

MOC Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Faculty and Disclosures

ACR Disclosure Statement
The ACR is an independent, professional organization that does not endorse specific procedures or products of any pharmaceutical/biotech concern. Educational activities provided by the ACR must demonstrate balance, independence, and scientific rigor. All those in a position to control the content of an activity must disclose all relevant financial relationship(s) with commercial interest(s). For this educational activity, all conflicts of interest have been resolved through peer review and revisions to ensure independence, evidence base, fair balance, and absence of commercial bias.

Faculty participating in an ACR-sponsored activity must disclose to the editorial team and audience any financial or other relationship(s) including, but not limited to:

  1. Stock, stock options or bond holdings in a for-profit corporation or self-directed pension plan
  2. Research grants
  3. Employment (full or part-time)
  4. Ownership or partnership
  5. Consulting fees or other remuneration (payment)
  6. Non-remunerative positions of influence such as officer, board member, trustee, or public spokesperson
  7. Receipt of royalties
  8. Speakers' bureau
  9. Other

The faculty reported the following disclosures.

  • Speaker: Maureen Mayes, MD - Boehringer-Ingelheim5, Eicos/CiviBio5, Corbus5, EMD-Serono5, Galapagos5, GSK5, CSL-Behring5, Reata5, Sanofi5
  • Question Author: Tracy Frech, MD - No relevant financial relationships to disclose
  • Question Author: Marcus Snow, MD - No relevant financial relationships to disclose

Contact Info / Inquiries

education@rheumatology.org
404-633-3777, ext. 381

© 2020 American College of Rheumatology.  All rights reserved.  Website & Privacy Policies | Sitemap | Help | Contact Us